title: Use of alternative therapies in menopause.
abstract: Hormone replacement therapy has traditionally been used to treat the accompanying symptoms of oestrogen deficiency in menopause. However, not all women can, or prefer to, receive this treatment and alternatives should be considered to reduce the increased risk of osteoporosis and heart disease in menopausal women. This chapter reviews the current literature on the efficacy of phyto-oestrogens in preventing cardiovascular disease, various cancers and osteoporosis, as well as treating the vasomotor and other menopause-related symptoms. Select herbal therapies, as well as selective oestrogen receptor modulators, are also considered.
authors.affiliation: Department of Obstetrics and Gynecology, Columbia University, New York, NY 10032, USA.
authors.forename: Michelle P
authors.initials: MP
authors.lastname: Warren
authors.forename: Barbara
authors.initials: B
authors.lastname: Shortle
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Dominguez
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control; D004967:Estrogens / Q000172:deficiency* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control; D007529:Isoflavones / Q000627:therapeutic use; D017705:Lignans / Q000627:therapeutic use; D008593:Menopause; D008875:Middle Aged; D009369:Neoplasms / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D008517:Phytotherapy; D028321:Plant Preparations / Q000627:therapeutic use; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
chemical_list: D004967:Estrogens; D007529:Isoflavones; D017705:Lignans; D028321:Plant Preparations; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride